Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports

Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports

Highlights/Take-away message 1. The Chimpanzee Adenovirus-vectored Vaccine (ChAdOx1 nCoV-19 vaccine) has been widely used in Himalayan Country, Nepal and India. 2. Apart from other minor side effects, delayed thromboses in superficial vein have been reported after vaccination of ChAdOx1 nCoV-19 vacc...

Full description

Bibliographic Details
Main Authors:	Mukesh Kumar Sah, Bishnu Mohan Singh, Puja Sinha, Prerit Devkota, Sudhira Kumari Yadav, John Shrestha, Ashis Shrestha
Format:	Article
Language:	English
Published:	BMC 2022-05-01
Series:	Journal of Medical Case Reports
Subjects:	ChAdOx1 nCoV-19 Covishield vaccine Superficial venous thrombosis (SVT) Venous thrombosis Superficial saphenous vein (SSV) COVID 19
Online Access:	https://doi.org/10.1186/s13256-022-03407-6

Similar Items

Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine
by: Ashish Chavan, et al.

ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review
by: Homa Faghihi, et al.
Published: (2023-11-01)

Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
by: Kim SH, et al.
Published: (2018-06-01)

Superficial venous thrombosis: disease progression and evolving treatment approaches
by: Litzendorf M, et al.
Published: (2011-08-01)

Endovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up
by: K. A. Kaperiz, et al.
Published: (2023-12-01)

Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
by: Shane P. Comer, et al.
Published: (2022-02-01)

A Review on Suggested Mechanisms in Thrombocytopenia and Thrombosis Following ChAdOx1 nCoV-19 Vaccination
by: Negar Mottaghi Dastgerdi, et al.
Published: (2021-11-01)

Palatal petechiae: an uncommon oral adverse effect of COVID-19 vaccine
by: Bhawna Sayare, et al.
Published: (2021-09-01)

A review on superficial venous thrombosis of the lower extremities
by: Yung-Wei Chi, et al.
Published: (2019-01-01)

Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination
by: Jimin Hwang, et al.
Published: (2022-03-01)

Superficial venous thrombosis: Single-center experience and current recommendations
by: Sasank Kalipatnapu, et al.
Published: (2019-01-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
by: Jer-Hwa Chang, et al.
Published: (2022-02-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
by: Tamara Garibashvili, et al.
Published: (2022-06-01)

FEATURES OF SUPERFICIAL VEIN THROMBOSIS IN PATIENTS WITH A LARGE DIAMETER OF GREAT SAPHENOUS VEIN
by: Viktoriia Mishura, et al.
Published: (2022-09-01)

Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination
by: Amarendra Kumar Shukla, et al.
Published: (2022-06-01)

Superficial Venous Thrombosis: A Comprehensive Review
by: Marco Mangiafico, et al.
Published: (2024-02-01)

Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
by: Yasir Khan, et al.
Published: (2019-11-01)

The superficial venous pump
by: Konstantin Mazayshvili
Published: (2018-05-01)

Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination
by: Szu-Ting Huang, et al.
Published: (2022-12-01)

Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study
by: Shao SC, et al.
Published: (2023-09-01)

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry
by: Philippe Debourdeau, et al.
Published: (2023-03-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
by: Jinnam Kim, et al.
Published: (2023-04-01)

Superficial vein thrombosis and deep vein thrombosis – a comparison
by: Zbigniew Krasiński, et al.
Published: (2017-09-01)

An autopsy case of cerebral arterial thrombosis after vaccination with ChAdOx1 nCOV-19
by: Hyeji Yang, et al.
Published: (2022-08-01)

Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield<sup>TM</sup>) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021
by: Sharan Murali, et al.
Published: (2022-06-01)

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
by: Josue Antonio Estrada, et al.
Published: (2022-04-01)

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
by: Jie Wei, et al.
Published: (2023-02-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
by: Tarana Sarwat, et al.
Published: (2022-01-01)

Case Series of Cerebral Venous Sinus Thrombosis After COVID-19 Vaccination
by: Mohsen Soltani, et al.
Published: (2023-07-01)

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
by: Prasad S. Kulkarni, et al.
Published: (2024-12-01)

Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID‐19 AstraZeneca vaccination: A case report
by: Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Published: (2022-11-01)

Management of superficial venous thrombosis based on individual risk profiles: protocol for the development and validation of three prognostic prediction models in large primary care cohorts
by: F. S. van Royen, et al.
Published: (2021-08-01)

Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination
by: Guan-Yi Li, et al.
Published: (2022-08-01)

Safety and efficacy of outpatient endovenous laser ablation in patients 75 years and older: a propensity score-matched analysis
by: Hak Hong Keo, et al.
Published: (2019-06-01)

Factors Associated with the Evolution of Superficial Vein Thrombosis and Its Impact on the Quality of Life: Results from a Prospective, Unicentric Study
by: Blanca Ros Gómez, et al.
Published: (2024-01-01)

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study
by: Thachanun Porntharukchareon, et al.
Published: (2023-08-01)

Case report: Early onset Marin-Amat syndrome after receiving ChAdOx1 nCoV-19 vaccination
by: Ping-Feng Tsai, et al.
Published: (2022-11-01)

Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India
by: Anil Bhandari, et al.
Published: (2022-01-01)

Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
by: Minji Jeon, et al.
Published: (2021-09-01)

Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome
by: Tobias Braun, et al.
Published: (2021-11-01)